Hollsteen
← Credo

Equity incl. NCI

Balance – as of period end · $M

QuartersFiscal years

$MEquity incl. NCI · Q1 FY2016: missing – No verified SEC value extracted, although the company reports this metric in other periods.Equity incl. NCI · Q2 FY2016: missing – No verified SEC value extracted, although the company reports this metric in other periods.Equity incl. NCI · Q3 FY2016: missing – No verified SEC value extracted, although the company reports this metric in other periods.Equity incl. NCI · Q4 FY2016: missing – No verified SEC value extracted, although the company reports this metric in other periods.Equity incl. NCI · Q1 FY2017: missing – No verified SEC value extracted, although the company reports this metric in other periods.Equity incl. NCI · Q2 FY2017: missing – No verified SEC value extracted, although the company reports this metric in other periods.Equity incl. NCI · Q3 FY2017: missing – No verified SEC value extracted, although the company reports this metric in other periods.Equity incl. NCI · Q4 FY2017: missing – No verified SEC value extracted, although the company reports this metric in other periods.Equity incl. NCI · Q1 FY2018: missing – No verified SEC value extracted, although the company reports this metric in other periods.Equity incl. NCI · Q2 FY2018: missing – No verified SEC value extracted, although the company reports this metric in other periods.Equity incl. NCI · Q3 FY2018: missing – No verified SEC value extracted, although the company reports this metric in other periods.Equity incl. NCI · Q4 FY2018: missing – No verified SEC value extracted, although the company reports this metric in other periods.Equity incl. NCI · Q1 FY2019: missing – No verified SEC value extracted, although the company reports this metric in other periods.Equity incl. NCI · Q2 FY2019: missing – No verified SEC value extracted, although the company reports this metric in other periods.Equity incl. NCI · Q3 FY2019: missing – No verified SEC value extracted, although the company reports this metric in other periods.Equity incl. NCI · Q4 FY2019: −$13.0M · 10-K 0001628280-22-016593 filed Jun 8, 2022Equity incl. NCI · Q1 FY2020: missing – No verified SEC value extracted, although the company reports this metric in other periods.Equity incl. NCI · Q2 FY2020: missing – No verified SEC value extracted, although the company reports this metric in other periods.Equity incl. NCI · Q3 FY2020: missing – No verified SEC value extracted, although the company reports this metric in other periods.Equity incl. NCI · Q4 FY2020: −$9.0M · 10-K 0001628280-22-016593 filed Jun 8, 2022Equity incl. NCI · Q1 FY2021: −$14.0M · 10-Q 0001628280-22-005722 filed Mar 10, 2022Equity incl. NCI · Q2 FY2021: −$50.0M · 10-Q 0001628280-22-005722 filed Mar 10, 2022Equity incl. NCI · Q3 FY2021: −$54.0M · 10-Q 0001628280-22-005722 filed Mar 10, 2022Equity incl. NCI · Q4 FY2021: −$55.0M · 10-K 0001628280-22-016593 filed Jun 8, 2022Equity incl. NCI · Q1 FY2022: −$66.0M · 10-Q 0001628280-22-005722 filed Mar 10, 2022Equity incl. NCI · Q2 FY2022: −$69.0M · 10-Q 0001628280-22-005722 filed Mar 10, 2022Equity incl. NCI · Q3 FY2022: $306M · 10-Q 0001628280-22-005722 filed Mar 10, 2022Equity incl. NCI · Q4 FY2022: $334M · 10-K 0001628280-22-016593 filed Jun 8, 2022Equity incl. NCI · Q1 FY2023: $342M · 10-Q 0001628280-22-024164 filed Sep 1, 2022Equity incl. NCI · Q2 FY2023: $344M · 10-Q 0001628280-22-031244 filed Dec 1, 2022Equity incl. NCI · Q3 FY2023: $355M · 10-Q 0001628280-23-006114 filed Mar 2, 2023Equity incl. NCI · Q4 FY2023: $348M · 10-K 0001628280-23-023187 filed Jun 23, 2023Equity incl. NCI · Q1 FY2024: $347M · 10-Q 0001628280-23-030893 filed Aug 29, 2023Equity incl. NCI · Q2 FY2024: $350M · 10-Q 0001628280-23-040371 filed Nov 30, 2023Equity incl. NCI · Q3 FY2024: $534M · 10-Q 0001628280-24-007677 filed Feb 28, 2024Equity incl. NCI · Q4 FY2024: $540M · 10-K 0001628280-24-029629 filed Jun 24, 2024Equity incl. NCI · Q1 FY2025: $553M · 10-Q 0001628280-24-039562 filed Sep 5, 2024Equity incl. NCI · Q2 FY2025: $568M · 10-Q 0001628280-24-049786 filed Dec 3, 2024Equity incl. NCI · Q3 FY2025: $618M · 10-Q 0001628280-25-011738 filed Mar 10, 2025Equity incl. NCI · Q4 FY2025: $682M · 10-K 0001628280-25-033813 filed Jul 2, 2025Equity incl. NCI · Q1 FY2026: $781M · 10-Q 0001807794-25-000021 filed Sep 4, 2025Equity incl. NCI · Q2 FY2026: $1.3B · 10-Q 0001628280-25-054549 filed Dec 2, 2025Equity incl. NCI · Q3 FY2026: $1.8B · 10-Q 0001628280-26-014017 filed Mar 3, 2026Equity incl. NCI · Q4 FY2026: $2.1B · 10-K 0001628280-26-043303 filed Jun 15, 2026Equity incl. NCI · Q1 FY2027: $2.7B · 10-Q 0001628280-26-060111 filed Sep 2, 2026missing2,728−13Q1 FY2016Q1 FY2027Q3 FY2020
$MEquity incl. NCI · Q3 FY2019: missing – No verified SEC value extracted, although the company reports this metric in other periods.Equity incl. NCI · Q4 FY2019: −$13.0M · 10-K 0001628280-22-016593 filed Jun 8, 2022Equity incl. NCI · Q1 FY2020: missing – No verified SEC value extracted, although the company reports this metric in other periods.Equity incl. NCI · Q2 FY2020: missing – No verified SEC value extracted, although the company reports this metric in other periods.Equity incl. NCI · Q3 FY2020: missing – No verified SEC value extracted, although the company reports this metric in other periods.Equity incl. NCI · Q4 FY2020: −$9.0M · 10-K 0001628280-22-016593 filed Jun 8, 2022Equity incl. NCI · Q1 FY2021: −$14.0M · 10-Q 0001628280-22-005722 filed Mar 10, 2022Equity incl. NCI · Q2 FY2021: −$50.0M · 10-Q 0001628280-22-005722 filed Mar 10, 2022missing−50−13−9Q3 FY2019Q2 FY2021Q3 FY2020
Q3 FY2020
missing

No verified SEC value extracted, although the company reports this metric in other periods.

All values (27)
PeriodValue ($M)Status
Q1 FY20272,728reported
Q4 FY20262,064reported
Q3 FY20261,849reported
Q2 FY20261,286reported
Q1 FY2026781reported
Q4 FY2025682reported
Q3 FY2025618reported
Q2 FY2025568reported
Q1 FY2025553reported
Q4 FY2024540reported
Q3 FY2024534reported
Q2 FY2024350reported
Q1 FY2024347reported
Q4 FY2023348reported
Q3 FY2023355reported
Q2 FY2023344reported
Q1 FY2023342reported
Q4 FY2022334reported
Q3 FY2022306reported
Q2 FY2022−69reported
Q1 FY2022−66reported
Q4 FY2021−55reported
Q3 FY2021−54reported
Q2 FY2021−50reported
Q1 FY2021−14reported
Q4 FY2020−9reported
Q4 FY2019Noneerror

18 periods without value hidden · Show gaps with reason · CSV with all sources · Technical ID: equity_total

More metrics for Credo

Income statement

Per share

Balance sheet

Cash flow

Revenue by segment/product/region